CN101878213B - α-氟烷基丁苯那嗪和二氢丁苯那嗪成像剂和探针 - Google Patents

α-氟烷基丁苯那嗪和二氢丁苯那嗪成像剂和探针 Download PDF

Info

Publication number
CN101878213B
CN101878213B CN2008801188947A CN200880118894A CN101878213B CN 101878213 B CN101878213 B CN 101878213B CN 2008801188947 A CN2008801188947 A CN 2008801188947A CN 200880118894 A CN200880118894 A CN 200880118894A CN 101878213 B CN101878213 B CN 101878213B
Authority
CN
China
Prior art keywords
compound
group
compounds
fluoroalkyl
tetrabenazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008801188947A
Other languages
English (en)
Chinese (zh)
Other versions
CN101878213A (zh
Inventor
M·J·里谢尔
B·F·约翰逊
K·K·D·阿马拉辛赫
S·R·迪恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Electric Co
Original Assignee
General Electric Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/947,275 external-priority patent/US7910738B2/en
Priority claimed from US11/947,215 external-priority patent/US7902364B2/en
Application filed by General Electric Co filed Critical General Electric Co
Publication of CN101878213A publication Critical patent/CN101878213A/zh
Application granted granted Critical
Publication of CN101878213B publication Critical patent/CN101878213B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN2008801188947A 2007-11-29 2008-11-25 α-氟烷基丁苯那嗪和二氢丁苯那嗪成像剂和探针 Expired - Fee Related CN101878213B (zh)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US11/947275 2007-11-29
US11/947,215 2007-11-29
US11/947,275 US7910738B2 (en) 2007-11-29 2007-11-29 Intermediates for alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes
US11/947,215 US7902364B2 (en) 2007-11-29 2007-11-29 Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes
US11/947215 2007-11-29
US11/947,275 2007-11-29
US12/174167 2008-07-16
US12/174,167 2008-07-16
US12/174,167 US8053578B2 (en) 2007-11-29 2008-07-16 Alpha-fluoroalkyl dihydrotetrabenazine imaging agents and probes
PCT/US2008/084601 WO2009070552A1 (en) 2007-11-29 2008-11-25 Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes

Publications (2)

Publication Number Publication Date
CN101878213A CN101878213A (zh) 2010-11-03
CN101878213B true CN101878213B (zh) 2013-05-29

Family

ID=40297912

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008801188947A Expired - Fee Related CN101878213B (zh) 2007-11-29 2008-11-25 α-氟烷基丁苯那嗪和二氢丁苯那嗪成像剂和探针

Country Status (5)

Country Link
US (1) US8053578B2 (cg-RX-API-DMAC7.html)
EP (2) EP2217599A1 (cg-RX-API-DMAC7.html)
JP (1) JP2011505363A (cg-RX-API-DMAC7.html)
CN (1) CN101878213B (cg-RX-API-DMAC7.html)
WO (1) WO2009070552A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120003330A1 (en) * 2010-06-01 2012-01-05 Auspex Pharmaceuticals, Inc. Benzoquinolone inhibitors of vmat2
EP2758041B1 (de) * 2011-09-20 2021-01-13 Basf Se Niedermolekulare modulatoren des kälte-menthol-rezeptors trpm8 und deren verwendung
US9550780B2 (en) 2012-09-18 2017-01-24 Auspex Pharmaceuticals, Inc. Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
JP6362601B2 (ja) 2012-09-18 2018-07-25 オースペックス・ファーマシューティカルズ・インコーポレイテッドAuspex Pharmaceuticals, Inc. 小胞モノアミン輸送体2の重水素化ベンゾキノリン阻害剤の製剤薬物動態
EA202091397A1 (ru) * 2013-01-31 2020-09-04 Ауспекс Фармацетикалс, Инк. Бензохинолоновые ингибиторы vmat2
CA2925562A1 (en) * 2013-09-27 2015-04-02 Auspex Pharmaceuticals, Inc. Benzoquinolone inhibitors of vmat2
WO2015077521A1 (en) * 2013-11-22 2015-05-28 Auspex Pharmaceuticals, Inc. Benzoquinoline inhibitors of vesicular monoamine transporter 2
AU2014357518A1 (en) 2013-12-03 2016-06-09 Auspex Pharmaceuticals, Inc. Methods of manufacturing benzoquinoline compounds
KR20160111999A (ko) * 2014-01-27 2016-09-27 오스펙스 파마슈티칼스, 인코포레이티드 소포성 모노아민 수송체 2의 벤조퀴놀린 억제제
PL3265085T3 (pl) 2015-03-06 2022-11-07 Auspex Pharmaceuticals, Inc. Sposoby leczenia zaburzeń związanych z nieprawidłowymi ruchami mimowolnymi
PE20240822A1 (es) * 2021-03-22 2024-04-18 Neurocrine Biosciences Inc Inhibidores de vmat2 y metodos de uso
WO2026050236A1 (en) 2024-08-27 2026-03-05 Neurocrine Biosciences, Inc. Muscarinic receptor agonist in combination with a vesicular monoamine transporter 2 inhibitor, for use in the treatment of a neurological or psychiatric disorder

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193998A (en) * 1977-06-15 1980-03-18 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt 1,2,3,4,6,7-Hexahydro-11BαH-benzo[a]quinolizine-derivatives
WO1993016730A1 (en) * 1992-02-28 1993-09-02 The Trustees Of The University Of Pennsylvania Iodine derivatives of tetrabenazyne
CN1980924A (zh) * 2004-02-11 2007-06-13 剑桥实验室(爱尔兰)有限公司 二氢丁苯那嗪类及包含它们的药用组合物
WO2007130365A2 (en) * 2006-05-02 2007-11-15 The Trustees Of The University Of Pennsylvania Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1068261B (de) * 1959-11-05 F. Hoffmann-La Roche £v Co. Aktiengesellschaft, Basel (Schweiz) Verfahren zur Herstellung von substituierten 2-Oxobenzo-chinollizinen
US2843591A (en) * 1958-07-15 Method for preparing same
CA2623794A1 (en) 2005-06-29 2007-01-11 The Trustees Of Columbia University In The City Of New York Use of dtbz for imaging endocrine pancreas and beta cell mass in type 1 diabetes
ES2318771T3 (es) 2005-08-06 2009-05-01 Cambridge Laboratories (Ireland) Limited 3,11b-cis-dihidrotetrabenazinas para el tratamiento de la esquizofrenia y otras psicosis.
US8008500B2 (en) 2007-06-08 2011-08-30 General Electric Company Intermediates useful for making tetrabenazine compounds
US7902364B2 (en) * 2007-11-29 2011-03-08 General Electric Company Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193998A (en) * 1977-06-15 1980-03-18 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt 1,2,3,4,6,7-Hexahydro-11BαH-benzo[a]quinolizine-derivatives
WO1993016730A1 (en) * 1992-02-28 1993-09-02 The Trustees Of The University Of Pennsylvania Iodine derivatives of tetrabenazyne
CN1980924A (zh) * 2004-02-11 2007-06-13 剑桥实验室(爱尔兰)有限公司 二氢丁苯那嗪类及包含它们的药用组合物
WO2007130365A2 (en) * 2006-05-02 2007-11-15 The Trustees Of The University Of Pennsylvania Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents

Also Published As

Publication number Publication date
EP2594568A1 (en) 2013-05-22
WO2009070552A1 (en) 2009-06-04
US20090142276A1 (en) 2009-06-04
JP2011505363A (ja) 2011-02-24
US8053578B2 (en) 2011-11-08
CN101878213A (zh) 2010-11-03
EP2217599A1 (en) 2010-08-18

Similar Documents

Publication Publication Date Title
CN101878213A (zh) α-氟烷基丁苯那嗪和二氢丁苯那嗪成像剂和探针
DK2634177T3 (en) TAU IMAGE SOUND
JP5597835B2 (ja) イメージング剤及びプローブとしてのフルオロアルキルテトラベナジンカルビノール化合物
US7919622B2 (en) Intermediates for fluorinated tetrabenazine carbinol compounds imaging agents and probes
CN105814023A (zh) tau成像探针
US7902364B2 (en) Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes
US7998962B2 (en) Enantiomers of 2'-Fluoralky1-6-nitroquipazine as serotonin transporter positron emission tomography imaging agents and antidepressant therapeutics
EP4168409B1 (en) Vmat2 inhibitors and methods of use
CN101998956B (zh) 氟化二氢丁苯那嗪醚成像剂和探针
US7910738B2 (en) Intermediates for alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes
EP3835293B1 (en) Monoamine oxidase b imaging probe
US7897769B2 (en) Intermediates for fluorinated dihydrotetrabenazine ether imaging agents and probes
US9186424B2 (en) Aryloxyanilide imaging agents
EP2247316B1 (en) Imaging the central nervous system
US8013161B1 (en) Fluoroalkyl tetrabenazine carbinol compounds as imaging agents and probes
US7897770B2 (en) Fluorinated dihydrotetrabenazine ether imaging agents and probes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130529

Termination date: 20151125

CF01 Termination of patent right due to non-payment of annual fee